Countermeasures
Covered
The countermeasures covered are determined
by the declarations issued by the Secretary
of Health and Human Services. Following
are all current declarations:
- Secretary’s
Declaration for the Use of H5N1 Vaccine
or (PDF-
50KB) (Federal Register notice,
February 1, 2007)
- Amendment
to January 26, 2007 Declaration Under
the Public Readiness and Emergency Preparedness
Act or (PDF
57KB) (Federal Register notice,
November 30, 2007)
- Anthrax
Countermeasures: Declaration Under the
Public Readiness and Emergency Preparedness
Act or (PDF
56KB) (Federal Register notice,
October 6, 2008)
- Pandemic
Countermeasures Amendment to H5N1 Declaration
Under the Public Readiness and Emergency
Preparedness Act or (PDF
52KB) (Federal Register notice,
October 17, 2008)
- Pandemic
Countermeasures: Declaration Under the
Public Readiness and Emergency Preparedness
Act or (PDF
58KB) (Federal Register notice,
October 17, 2008)
- Botulism
Countermeasures: Declaration Under the
Public Readiness and Emergency Preparedness
Act or (PDF
54KB) (Federal Register notice,
October 17, 2008)
- Smallpox
Countermeasures: Declaration Under the
Public Readiness and Emergency Preparedness
Act or (PDF
51KB) (Federal Register notice,
October 17, 2008)
- Acute
Radiation Syndrome Countermeasures:
Declaration Under the Public Readiness
and Emergency Preparedness Act or
(PDF
55KB) (Federal Register notice,
October 17, 2008)
A covered countermeasure, as defined
in section 319F-3(i)(1) of the Public
Health Service Act (PHS Act), means:
(A) a qualified pandemic or epidemic
product (as defined in section 319F-3(i)(7)
of the PHS Act);
(B) a security countermeasure (as defined
in section 319F-2(c)(1)(B) of the PHS
Act); or
(C) a drug (as such term is defined
in section 201(g)(1) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
321(g)(1)), biological product (as such
term is defined by section 351(i) of
this Act), or device (as such term is
defined by section 201(h) of the Federal
Food, Drug and Cosmetic Act (21 U.S.C.
321(h)) that is authorized for emergency
use in accordance with section 564 of
the Federal Food, Drug and Cosmetic
Act.
|
